Document is current
Any future updates will be listed below
-
Authors
Kuthi, Luca
Merkel, Eperke
Németh, Marianna
Veres, Boglárka
Szakács, Zoltán
Behon, Anett
Masszi, Richárd
Kis, Zsuzsanna
Papp, Roland
Molnár, Levente
Kovács, Attila
Kosztin, Annamária
Merkely, Béla https://orcid.org/0000-0001-6514-0723
Schwertner, Walter Richard
-
Funding
Funding for this research was provided by:
European Union (RRF-2.3.1-21-2022-00003)
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (TKP2021-EGA-23)
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (FK_23 OTKA (FK147312))
Semmelweis University
- License Information
-
More Information
Article History
Received: 28 February 2026
Accepted: 22 April 2026
First Online: 18 June 2026
Declarations
:
: AKos receives lecture fees from Biotronik, Astra Zeneca, Pfizer, Boehringer Ingelheim and consulting fee from Biotronik. BM receives direct personal payment from Boehringer Ingelheim, Daiichi Sankyo, DUKE Clinical Institut, Novartis, receives institutional grants (for the Heart and Vascular Center of Semmelweis University): from Biotronik, Boehringer Ingelheim, DUKE Clinical Institut, Eli Lilly, Novartis. AKov serves as Chief Medical Officer of Argus Cognitive, Inc outside the submitted paper. PR receives lecture fees from Biotronik, Medtronic, and Abbott. LM reports lecture fees from Biotronik, Medtronic, and Abbott outside the submitted work. MN receives lecture fees and grants from Biotronik, Boston Scientific, Egis and Medtronic. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
